Ask your surgeon for more information about Natrelle and visit GummyImplants.com

Similar documents
ALLODERM SELECT ALLODERM SELECT RESTORE

Information and resources for African Americans living with multiple myeloma and their caregivers

DIRECTIONS FOR USE. NATRELLE 133 Tissue Expanders. MAGNA-FINDER Xact. Directions for Use. with Magna-Site. Injection Sites

DIRECTIONS FOR USE. NATRELLE 133 Plus Tissue Expanders. MAGNA-FINDER Xact. Directions for Use. with Magna-Site. Injection Sites

CAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician.

Repliform. Tissue Regeneration Matrix. Instructions for Use. Distributed by:

TRELLIS COLLAGEN RIBBON

Form-Stable Cohesive Gel Implants: Advantages and Technical Essentials

A GUIDE TO THIS REFLECTIONS B RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication

Meso BioMatrix Acellular Peritoneum Matrix RECOMMENDED TECHNIQUE GUIDE. Recreating harmonious bodies for a new vision of rebirth.

PRO-STIM Injectable Inductive Graft Containing DONATED HUMAN TISSUE

MIIG INJECTABLE Graft The following languages are included in this packet:

Platelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States.

LEARN. about. Please see Important Safety Information on pages 3-5 and enclosed full Prescribing Information.

The Role of Adult Stem Cells in Personalized and Regenerative Medicine

PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec)

CADTH ISSUES IN EMERGING HEALTH TECHNOLOGIES

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Myeloma Bone Disease Current and Future Treatment. A Publication of The Bone and Cancer Foundation

Document number (version): RMP.NUS (3.0) Page 63 of 95

STEM CELLS BONE FRACTURE

Discover TruPRP. PRP the way you want it.

MEDPOR. Orbital Floor

Mutations : D: a permanent change made to one section of DNA

For personal use only

Artist Proof: Clotalyst. Autologous Serum Collection System

Surgical Adhesives in Facial Plastic Surgery

Correspondence should be addressed to Christopher Vashi;

Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords

PLTW Biomedical Science Medical Interventions Course Outline

Tabbed Tissue Expanders Improve Breast Symmetry Scores in Breast Reconstruction

REFERENCE CODE GDME1016FPR PUBLICATION DATE JULY 2013 HERNIA REPAIR CURRENT AND FUTURE PLAYERS

Quality ID #262: Image Confirmation of Successful Excision of Image-Localized Breast Lesion National Quality Strategy Domain: Patient Safety

BAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS AT AORN MEETING

DuraGen Secure. Dural Regeneration Matrix

Smouldering myeloma. Myeloma Infosheet Series. Other related conditions. Infoline:

Treatment: Nutrition and Medication

SCIENCE. VALUE. INNOVATION.

Diagnosis for Open Wounds as a Result of Cancer Resection

MITRAL VALVE REPAIR BACKGROUND

For personal use only

Functional Assessment and Clinical Outcome

RegenKit THT. Autologous Platelet Rich Plasma (A-PRP) Reference Guide. Biologics. Concentrated on Healing

Infra-red s Effect on Dentistry and the Immune System Presented by Dr. John L. Tate

Arthrex Angel TM System. Indication-specific PRP and PRF gel preparations

Alliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA

Health Reimbursement Account Preventive Care Program for Participants and Spouses

Germany Tissue Engineered - Skin Substitutes Market Outlook to 2020

Agenzia Italiana del Farmaco

This Infosheet explains what Monoclonal Gammopathy of Undetermined Significance (MGUS) is and how it is diagnosed and managed.

Future bound. Philips Ingenuity Core

Heat Transfer in Laser Tumor Excision

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Design and Development of Biomedical and Surgical Instruments in Biomedical Applications

MEDICAL WASTE MANAGEMENT STUDY NOTES

Guideline on core SmPC for human fibrinogen products

Wisconsin Folk Medicine

CapSure Permanent Fixation System

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

Update on the IVDR. Sue Spencer

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin

Participant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way.

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

Clinical Policy: Humate-P (Antihemophiliac Factor/von Willebrand Factor Complex Human) Reference Number: CP.MP.404

3. Human Biomedical Research. Defining Human Biomedical Research

HydroSet. Injectable HA Bone Substitute

The Power in You. TM

PREVELEAK Surgical sealant

Guidelines for the use of blood warming devices(aabb) Reference: 2002 AABB

Comprehensive Solutions

CAREGIVER GUIDE themmrf.org

HEMOSTASIS IN SURGERY

YOUR OWN LIFE

07/30/2013. Record of Revisions IRB Page 1 of 17

Santen Acquisition of InnFocus, Developer of MicroShunt Glaucoma Implant Device

Perioperative management of patients on warfarin requiring elective surgery Dr K Boyd, Mrs S Doyle

Introducing a new take on efficient workflow: Deeply integrated clinical applications

VIII. Validation Evaluation Comparative Chart Application Fields of PRP Advantages of MiroPRP for skin treatments MicroPRP and Mico-Mesotherapy

Section 8. To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS)

CRM and the Future of Healthcare Engagement

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

Tissue Expander Overfilling: Achieving New Dimensions of Customization in Breast Reconstruction

Immunotherapy in myeloma

Presenting SURGICEL Powder

All Savers Wellness. Capability Overview.

ADVANCING THE ART OF SINGLE-STAGE REPAIR

BIOLOGIC MEDICATIONS IN THE TREATMENT OF IBD. crohnsandcolitis.ca

Radiography Curriculum Analysis

IT S A GLOBAL LEADER. IT S PROVEN.

Molecular Diagnostics. Castle Medical LLC.

Transcription:

The #1 surgeon-preferred gummy implant collection in the US* Two-stage breast reconstruction starts with Natrelle 133 Series Tissue Expanders Natrelle 133 Series Tissue Expanders are made to match Natrelle INSPIRA Cohesive breast implants. This means that the tissue expander creates a space customized for the breast implant. A precise match ensures the confidence you and your surgeon expect with Natrelle. The #1 surgeon-preferred tissue expander* With 30 years of clinical experience. *Based on surgeon survey data, April 2017 (N = 89). Go gummy with Natrelle INSPIRA Cohesive breast implants Get a look and feel that s uniquely you with Natrelle INSPIRA Cohesive the gummiest round gel breast implant in the US. Designed to maintain its shape and upper pole fullness when held upright in your hand Designed for a full look Based on implant performance testing; significance inside the body has not been established. Your questions, answered 1 2 What s gummy about the gel in Natrelle INSPIRA Cohesive? The technical term for what s inside Natrelle INSPIRA Cohesive is highly cohesive gel that means that the gel has a gummy-like consistency that sticks together, holds its shape, and doesn t squish as much as other less cohesive silicone gels. How is Natrelle INSPIRA Cohesive different from other implants? Natrelle INSPIRA Cohesive is the most cohesive (gummiest) round gel breast implant in the US. This highly cohesive, gummy implant is designed to maintain its upper pole fullness. In other words, when you hold the implant upright in your hand, it s designed to keep its fullness at the top. Significance inside the body has not been established. Ask your surgeon for more information about Natrelle and visit GummyImplants.com

Natrelle Breast Implants Important Information Who may get breast implants? Natrelle Breast Implants are approved for women for the following: Breast augmentation for women at least 22 years old for silicone-filled implants. Breast augmentation for women at least 18 years old for saline-filled implants. Breast augmentation includes primary breast augmentation to increase breast size, as well as revision surgery to correct or improve the result of a primary breast augmentation surgery. Breast reconstruction. Breast reconstruction includes primary reconstruction to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality. Breast reconstruction also includes revision surgery to correct or improve the result of a primary breast reconstruction surgery. IMPORTANT SAFETY INFORMATION Who should NOT get breast implants? Women with active infection anywhere in their body. Women with existing cancer or precancer of their breast who have not received adequate treatment for those conditions. Women who are currently pregnant or nursing. What should I know before getting breast implants? Breast implants are not lifetime devices, and not necessarily a one-time surgery. Many of the changes to your breasts following implantation cannot be undone. If you later choose to have your implant(s) removed and not replaced, you may experience unacceptable dimpling, puckering, wrinkling, or other cosmetic changes of the breast, which may be permanent. Breast implants may affect your ability to breast-feed, either by reducing or eliminating milk production. Rupture of a silicone-filled breast implant is most often silent and may not be detected by you or your doctor. You should have an MRI 3 years after your surgery and then every 2 years after that for as long as you have your breast implants to determine if rupture is present. If implant rupture is noted on an MRI, you should have the implant removed, with or without replacement. With breast implants, a routine screening mammography and self-examinations for breast cancer will be more difficult. Ask your doctor to help you distinguish the implant from your breast tissue. Symptoms of a ruptured implant may be hard knots or lumps surrounding the implant or in the armpit, change or loss of size or shape of the breast or implant, pain, tingling, swelling, numbness, burning, or hardening. Tell your doctor of these symptoms and remove ruptured implants. Inform any other doctor who treats you of the presence of your implants to minimize the risk of damage to the implants. What should I tell my doctor? Tell your doctor if you have any of the following conditions, as the risks of breast implant surgery may be higher: Autoimmune diseases (for example, lupus and scleroderma). A weakened immune system (for example, currently taking drugs that weaken the body s natural resistance to disease). Planned chemotherapy following breast implant placement. Planned radiation therapy to the breast following breast implant placement. Conditions or medications that interfere with wound healing and blood clotting. Reduced blood supply to breast tissue. Clinical diagnosis of depression or other mental health disorders, including body dysmorphic disorder and eating disorders. Please discuss any history of mental health disorders with your surgeon prior to surgery. Patients with a diagnosis of depression or other mental health disorders should wait for resolution or stabilization of these conditions prior to undergoing breast implantation surgery. What are some complications with breast implants? Key complications are reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and severe capsular contracture (severe scar tissue around the implant). Other complications include asymmetry, nipple/breast/skin sensation changes, scarring, or wrinkling/rippling. Talk to your doctor about other complications. Talk to your doctor. For more information see the patient brochures at www.allergan.com/labeling/usa.htm. To report a problem with Natrelle Breast Implants, please call Allergan at 1-800-433-8871. Natrelle Breast Implants are available by prescription only. 2017 Allergan. All rights reserved. All trademarks are the property of their respective owners. Natrelle.com NAT110986 10/17 172448

The #1 surgeon-preferred s oft tissue matrix* *Based on surgeon survey data, April 2017 (N = 89). Get the soft tissue support you need with AlloDerm SELECT Regenerative Tissue Matrix Mastectomy may result in weakened or thin tissue, which may require reinforcement during breast reconstruction. Your surgeon may recommend AlloDerm SELECT Regenerative Tisse Matrix (an acellular dermal matrix, or ADM) as part of your breast reconstruction procedure. AlloDerm SELECT is a soft tissue matrix that helps to reinforce weakened or thin tissue. Ask your surgeon if AlloDerm SELECT is right for you. Your questions, answered 1 What is AlloDerm SELECT Regenerative Tissue Matrix? AlloDerm SELECT is a soft tissue matrix that helps to reinforce weakened or thin tissue. Your surgeon may recommend AlloDerm SELECT Regenerative Tisse Matrix (an acellular dermal matrix, or ADM) as part of your breast reconstruction procedure. 2 Is AlloDerm SELECT right for me? Only your plastic surgeon can determine if AlloDerm SELECT is right for you. Every woman s journey is different, and what might be a good fit for one person, may not be right for the next. Ask your care team which products are best for your unique situation. Ask your surgeon for more information about AlloDerm SELECT

Indication and Important Safety Information for AlloDerm SELECT Regenerative Tissue Matrix AlloDerm SELECT Regenerative Tissue Matrix is an acellular dermal matrix that comes from donated human tissue and is processed to remove cells while maintaining structure. AlloDerm SELECT RTM is intended for the replacement or repair of inadequate or damaged soft tissue. AlloDerm SELECT RTM is not a dural substitute or for veterinary use. Each package of AlloDerm SELECT RTM is for one-time use in one patient. Patients who are sensitive to any of the antibiotics listed on the product package or Polysorbate 20 should not receive AlloDerm SELECT RTM. AlloDerm SELECT RTM is available only through a licensed physician. Potential risks of surgical procedures associated with the use of a tissue matrix include, but are not limited to: wound or systemic infection, seroma, dehiscence, hypersensitive, allergic or other immune response, sloughing or failure of the tissue matrix, and disease transmission. This information is not intended to replace a discussion with your surgeon. It does not describe all the potential risks associated with the use of tissue matrix in surgical procedures. Every patient s situation is different, so please consult with your surgeon to determine if the use of AlloDerm SELECT RTM is right for you. Please see AlloDerm SELECT RTM Instructions for Use. AlloDerm SELECT and its design are trademarks of LifeCell Corporation, an Allergan affiliate. Allergan and its design are trademarks of Allergan, Inc. 2017 Allergan. All rights reserved. Allergan.com ALD110989 10/17 172448

The #1 surgeon-preferred fat transfer system* *Based on surgeon survey data, April 2017 (N = 89). Shape your breasts naturally with REVOLVE System REVOLVE System is a system for fat transfer that allows your surgeon to collect fat from one area of your body (such as your abdomen) and process that fat for transfer to your breasts. After processing with REVOLVE System, surgeons can use this purified fat to help replace the volume and shape that you ve lost after your mastectomy. Ask your surgeon if REVOLVE System is right for you. Fat transfer can enhance your overall breast shape by adding fullness where you need it the most Closed system design cleans and purifies fat in one sterile environment from start to finish Your questions, answered 1 How can fat transfer with REVOLVE System help me achieve my desired breast reconstruction results? Women who undergo a mastectomy are left with very thin tissue. Your surgeon may suggest fat transfer with REVOLVE System to replace the volume you ve lost and provide additional fullness. Ask your surgeon for more information about fat transfer with REVOLVE System

Indication and Important Safety Information for REVOLVE System The REVOLVE System is a single-use, sterile, disposable canister that is intended for processing, filtering, and transferring of autologous adipose tissue. The device is intended to be used by a physician to perform autologous fat grafting in aesthetic body-contouring procedures. Autologous fat-grafting should not be performed in the presence of any disease process that adversely affects wound healing and in patients who are in poor overall health. Some common adverse effects associated with autologous fat transfer are asymmetry, over- and/or undercorrection of the treatment site, tissue lumps, bleeding, and scarring. The REVOLVE System is available only through a licensed physician. This information is not intended to replace a discussion with your surgeon. It does not describe all the potential risks associated with fat grafting procedures. Every patient s situation is different, so please consult with your surgeon to determine if the use of REVOLVE System is right for you. Please see REVOLVE System Instructions for Use and User Manual. REVOLVE System and its design are trademarks of LifeCell Corporation, an Allergan affiliate. Allergan and its design are trademarks of Allergan, Inc. 2017 Allergan. All rights reserved. Allergan.com RVL110990 10/17 172448